⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DMAC News
DiaMedica Therapeutics Inc. Common Stock
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
businesswire.com
DMAC
Acute Ischemic Stroke - 7MM Market Size, Epidemiology, Competitive Landscape, and Forecast - 2036 | TNKase and Novel Pipelines Unlock Growth Opportunities
globenewswire.com
GNE
DMAC
Chronic Kidney Disease (CKD) Market Gains Momentum as Pipeline Innovation and Clinical Trials Reshape the Competitive Landscape in 2026
globenewswire.com
AZN
LLY
REGN
IONS
MRK
XRTX
DMAC
LSTA
Form 8-K
sec.gov
DMAC
DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026
businesswire.com
DMAC
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
DMAC
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
businesswire.com
DMAC
DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
businesswire.com
DMAC
DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026
businesswire.com
DMAC
Form 8-K
sec.gov
DMAC